These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 7879012

  • 1. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract] [Full Text] [Related]

  • 2. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115
    [No Abstract] [Full Text] [Related]

  • 3. Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts.
    Lin Y, Vandeputte M, Waer M.
    Transplant Proc; 1996 Apr; 28(2):952. PubMed ID: 8623477
    [No Abstract] [Full Text] [Related]

  • 4. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F, Chong A, Foster P, Sankary H, McChesney L, Williams JM, Frieders D, Williams JW.
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract] [Full Text] [Related]

  • 5. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats.
    Lin Y, Vandeputte M, Waer M.
    Transplantation; 1998 Feb 15; 65(3):332-9. PubMed ID: 9484748
    [Abstract] [Full Text] [Related]

  • 6. Natural killer cells, antibody-dependent cellular cytotoxicity, and complement synthesis by the xenograft itself play a role in xenograft rejection.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1995 Feb 15; 27(1):286-7. PubMed ID: 7879005
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS, Shen J, Xiao F, Blinder L, Foster P, Sankary H, Williams JW.
    Transplant Proc; 1996 Apr 15; 28(2):684. PubMed ID: 8623344
    [No Abstract] [Full Text] [Related]

  • 9. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1994 Oct 15; 26(5):3052. PubMed ID: 7940959
    [No Abstract] [Full Text] [Related]

  • 10. Blockade of induced xenoantigen expression prevents rejection after retransplantation of accommodated hamster-to-rat heart xenografts.
    Lin Y, Ji P, Xia G, Vandeputte M, Waer M.
    Transplantation; 1998 Feb 15; 65(3):340-5. PubMed ID: 9484749
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Leflunomide controls rejection in hamster to rat cardiac xenografts.
    Xiao F, Chong AS, Foster P, Sankary H, McChesney L, Koukoulis G, Yang J, Frieders D, Williams JW.
    Transplantation; 1994 Oct 15; 58(7):828-34. PubMed ID: 7940718
    [Abstract] [Full Text] [Related]

  • 13. Effect of leflunomide and cyclosporine on the occurrence of chronic xenograft lesions.
    Lin Y, Vandeputte M, Waer M.
    Kidney Int Suppl; 1995 Dec 15; 52():S23-8. PubMed ID: 8587278
    [Abstract] [Full Text] [Related]

  • 14. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F, Shen J, Chong A, Liu W, Foster P, Blinder HL, Sankary H, McChesney L, Mital D, Williams JW.
    Transplant Proc; 1996 Apr 15; 28(2):691-2. PubMed ID: 8623348
    [No Abstract] [Full Text] [Related]

  • 15. Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
    Hasan RI, Sriwatanawongsa V, Wallwork J, White DJ.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):421-2. PubMed ID: 8438362
    [No Abstract] [Full Text] [Related]

  • 16. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats.
    Lin Y, Vandeputte M, Waer M.
    Transplant Proc; 1996 Apr 15; 28(2):741. PubMed ID: 8623376
    [No Abstract] [Full Text] [Related]

  • 17. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model.
    Yin D, Ma LL, Blinder L, Shen J, Sankary H, Williams JW, Chong AS.
    J Immunol; 1998 Aug 15; 161(4):2044-51. PubMed ID: 9712078
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats.
    Lin Y, Segers C, Waer M.
    Transplant Proc; 1996 Dec 15; 28(6):3036. PubMed ID: 8962178
    [No Abstract] [Full Text] [Related]

  • 20. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA, Cramer DV, Tuso PJ, Chapman FA, Wang HK, Makowka L.
    J Heart Lung Transplant; 1994 Dec 15; 13(3):489-97. PubMed ID: 8061026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.